Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

10.11.2017 / 14:56
The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Title: Dr.
First name: Georg F.
Last name(s): Baur

2. Reason for the notification

a) Position / status
Position: Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
Heidelberg Pharma AG

b) LEI
391200E09XYBYITR1W32 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Derivative
ISIN: DE000A2GSZC6

b) Nature of the transaction
Granting of 31,268 subscription rights on convertible bonds

c) Price(s) and volume(s)
Price(s) Volume(s)
0 EUR 0 EUR

d) Aggregated information
Price Aggregated volume
0 EUR 0.0000 EUR

e) Date of the transaction
2017-11-09; UTC+1

f) Place of the transaction
Outside a trading venue


10.11.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language: English
Company: Heidelberg Pharma AG
Schriesheimer Str. 101
68526 Ladenburg
Germany
Internet: www.heidelberg-pharma.com

 
End of News DGAP News Service

38769  10.11.2017